PECAM1 and breast carcinoma: To conclude, ITZ-siRNAVEGF-NPs could reduce VEGF and CD31 expression through the synergistic effect of ITZ and VEGF siRNA and inhibited growth and angiogenesis of breast cancer in vivo.